MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Neuroprotective agents"

  • 2017 International Congress

    Piper betle L. Attenuates 6-OHDA Induced Apoptosis in SH-SY5Y Cells and Neuronal Injury in Caenorhabditis elegans Parkinson’s Model

    G. Shanmugam, A. Mohankumar, P. Sundararaj (Coimbatore, India)

    Objective: To explore the anti-apoptotic effects of Piper bitle leaf extract (PLE) on 6-OHDA induced cellular injury in human neuroblastoma cell SH-SY5Y. To analyse the neuroprotective…
  • 2017 International Congress

    Role of Apocyanin in modulating glial cell functions and associated inflammatory response in Lipopolysaccharide induced Parkinson’s disease model.

    N. Sharma, B. Nehru (Chandigarh, India)

    Objective: To explore the effect of apocyanin on glia mediated inflammatory response and α-synuclein aggregation in single intranigral LPS induced PD model Background: Converging lines…
  • 2017 International Congress

    MANF protects dopamine neurons and locomotion defect from Neurotoxin/Human alpha-synuclein-induced progressive Parkinson’s disease models in C.elegans.

    Z. Zhang (Shanghai, China)

    Objective: To study whether Mesencephalic astrocyte-derived neurotrophic factor (MANF) has beneficial effects in parkinson disease and its intracellular mechanisms.  Background: The distinguishing feature of Parkinson’s…
  • 2017 International Congress

    Neuroprotective effects of antidepressant mirtazapine against dopaminergic neurodegeneration in cultured cells and in parkinsonian mice possibly by targeting astrocytes

    M. Asanuma, I. Miyazaki, R. Kikuoka, S. Murakami, N. Isooka, Y. Kitamura (Okayama, Japan)

    Objective: In this study, we examined neuroprotective effects of mirtazapine and involvement of astrocytes in the effects using primary cultured cells and parkinsonian mice. Background:…
  • 2017 International Congress

    Study of neuroprotective effects of Ginsenside Rg3 , the prototypal epigenetic Sirtuin-1 activator, in targeting microglia activation and neurotrophic factor (NF) neural plasticity in MPTP model of Parkinson’s disease (PD)

    H. Raheb, J. Hou, S. Chiu (London, ON, Canada)

    Objective: 1) to examine whether the phyto-neurosteroid: Ginsenoside Rg3 recently demonstrated to activate the epigenetic SIRTI signaling, will rescue the motor impairment in rodent model…
  • 2017 International Congress

    Curcumin I prevents the developmental defective sensorimotor patterns resulted from Lead poisoning in rat

    H. BENAMMI, O. EL HIBA, H. GAMRANI (Marrakech, Morocco)

    Objective: In the present investigation, we evaluated the effect of prenatal exposure of rats to lead from neonatal to adult age on the sensorimotor performances…
  • 2017 International Congress

    Serum cholesterol levels over time and risk of Parkinson’s disease

    V. Rozani, T. Gurevich, N. Giladi, B. El-Ad, J. Tsamir, B. Hemo, C. Peretz (Tel A viv, Israel)

    Objective: To evaluate the association of serum cholesterol levels over time with the risk of Parkinson's disease (PD); among statin-free individuals. Background: High levels of…
  • 2017 International Congress

    Variation in Longevity Gene KLOTHO Associates with Measures of Resilience Against Parkinson’s Disease

    N. Luthra, J. Ostrem, D. Dubal (San Francisco, CA, USA)

    Objective: We investigated whether carrying one copy of the protective haplotype “KL-VS” of the longevity gene KLOTHO is associated with better cognitive functioning and/or attenuated…
  • 2017 International Congress

    Neuroactive steroids reverse the dopaminergic neurotransmission defectiveness in chronic hepatic (HE) encephalopathy: a possible involvement in HE related parkinsonism

    O. El Hiba, A. EL Khiat, H. Gamrani (EL Jadida, Morocco)

    Objective: In the present study, we describe the changes of the dopaminergic system occurring in the cirrhotic rats and concomitantly we investigated the effect of…
  • 2017 International Congress

    Relationship between Insulin-like Growth Factor-1 and characteristics of physical activity in patients with Parkinson’s disease

    K. Nagaki, M. Ikenaga, S. Fujioka, Y. Tsuboi (fukuoka, Japan)

    Objective: To clarify the characteristics of decreased physical activity and relationship between physical activity intensity and Insulin-like Growth Factor-1 (IGF-1) in patients with Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley